1. Home
  2. MNOV vs CAAS Comparison

MNOV vs CAAS Comparison

Compare MNOV & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.46

Market Cap

137.8M

Sector

Health Care

ML Signal

N/A

CAAS

China Automotive Systems Inc.

N/A

Current Price

$4.13

Market Cap

134.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
MNOV
CAAS
Founded
2000
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
137.8M
134.9M
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
MNOV
CAAS
Price
$1.46
$4.13
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $8.25
N/A
AVG Volume (30 Days)
★ 57.5K
10.6K
Earning Date
11-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,360,807.00
N/A
Revenue This Year
$78.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.97
Revenue Growth
★ 194.15
N/A
52 Week Low
$1.22
$4.00
52 Week High
$3.90
$5.64

Technical Indicators

Market Signals
Indicator
MNOV
CAAS
Relative Strength Index (RSI) 42.72 32.28
Support Level $1.28 $4.06
Resistance Level $1.54 $4.52
Average True Range (ATR) 0.06 0.08
MACD 0.02 -0.01
Stochastic Oscillator 51.25 4.65

Price Performance

Historical Comparison
MNOV
CAAS

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm, through its subsidiary, is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series of power steering models, including rack and pinion power steering, integral power steering, electronic power steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: